GlassScriptPhysician profile
Edmund Burton Sciore
NPI 1356034854
$831.62
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $323 · 2024: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $106.21 | 2023-2024 | Rexulti, Abilify Asimtufii |
| Lilly USA, LLC | $95.92 | 2023 | Mounjaro, Jardiance |
| Abbvie INC. | $83.81 | 2023-2024 | |
| Jazz Pharmaceuticals INC. | $81.71 | 2023-2024 | |
| Novo Nordisk INC | $76.72 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| Axsome Therapeutics, INC. | $61.37 | 2024 | Auvelity, Sunosi |
| Amgen INC. | $53.31 | 2023-2024 | Otezla, Repatha |
| Halozyme INC | $48.21 | 2023 | |
| Idorsia Pharmaceuticals US INC | $34.25 | 2023-2024 | Quviviq |
| Pfizer INC. | $33.69 | 2023-2024 | |
| Harmony Biosciences LLC | $27.87 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $23.19 | 2024 | Airsupra |
| Corium, LLC | $21.10 | 2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $18.22 | 2024 | Trintellix |
| Glaxosmithkline, LLC. | $18.01 | 2024 | Arexvy, Shingrix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $17.93 | 2024 | Lumryz |
| Currax Pharmaceuticals LLC | $16.76 | 2024 | Contrave, Onzetra Xsail |
| Exact Sciences Corporation | $13.34 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edmund Sciore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.